Reference
Luan F, et al. Cost Effective Prevention of CMV Infection and Its Long-Term Consequence. American Transplant Congress - 13th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation : abstr. 505, 18 May 2013.
Rights and permissions
About this article
Cite this article
Valganciclovir for CMV prevention better option, cost saving. PharmacoEcon Outcomes News 679, 7 (2013). https://doi.org/10.1007/s40274-013-0438-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0438-y